- Home
- KOD vs DJT Comparison
KOD vs DJT Comparison
Compare KOD & DJT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KOD | DJT |
|---|---|---|
| Founded | 2009 | 2021 |
| Country | United States | United States |
| Employees | N/A | 31 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.5B |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | KOD | DJT |
|---|---|---|
| Price | $30.52 | $8.24 |
| Analyst Decision | Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $35.43 | N/A |
| AVG Volume (30 Days) | 564.2K | ★ 4.1M |
| Earning Date | 05-14-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.43 | $7.86 |
| 52 Week High | $47.84 | $21.65 |
Technical Indicators
Market Signals| Indicator | KOD | DJT |
|---|---|---|
| Relative Strength Index (RSI) | 31.89 | 41.76 |
| Support Level | $21.13 | $8.08 |
| Resistance Level | $46.72 | $9.65 |
| Average True Range (ATR) | 2.52 | 0.51 |
| MACD | -0.54 | 0.04 |
| Stochastic Oscillator | 1.14 | 21.79 |
Price Performance
Historical ComparisonAbout KOD Kodiak Sciences Inc
Kodiak Sciences Inc has developed a new technology platform, the Antibody Biopolymer Conjugate (ABC) platform, for retinal medicines. Its investigational medicine, tarcocimab tedromer (Zenkuda or tarcocimab), is an anti-VEGF therapy built on Kodiak's proprietary ABC platform. Another investigational medicine, KSI-501, is an anti-interleukin 6, or IL-6, VEGF-trap bispecific therapy built on the ABC platform and is being developed for high-prevalence retinal vascular diseases and intended to address the unmet needs of extended durability and targeting disease biology beyond VEGF for differentiated efficacy. Its third investigational medicine, KSI-101, is a high-strength (100 mg/mL) bispecific protein targeting IL-6 and VEGF.
About DJT Trump Media & Technology Group Corp.
Trump Media & Technology Group Corp is a media and technology company rooted in social media, digital streaming, information technology infrastructure, and more. Its initial product launch will focus on its social media platform, Truth Social, which encourages an open, free, and honest conversation without discriminating against political ideology.